» Articles » PMID: 30982891

High-Order Epistasis in Catalytic Power of Dihydrofolate Reductase Gives Rise to a Rugged Fitness Landscape in the Presence of Trimethoprim Selection

Overview
Journal Mol Biol Evol
Specialty Biology
Date 2019 Apr 16
PMID 30982891
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

Evolutionary fitness landscapes of several antibiotic target proteins have been comprehensively mapped showing strong high-order epistasis between mutations, but understanding these effects at the biochemical and structural levels remained open. Here, we carried out an extensive experimental and computational study to quantitatively understand the evolutionary dynamics of Escherichia coli dihydrofolate reductase (DHFR) enzyme in the presence of trimethoprim-induced selection. To facilitate this, we developed a new in vitro assay for rapidly characterizing DHFR steady-state kinetics. Biochemical and structural characterization of resistance-conferring mutations targeting a total of ten residues spanning the substrate binding pocket of DHFR revealed distinct changes in the catalytic efficiencies of mutated DHFR enzymes. Next, we measured biochemical parameters (Km, Ki, and kcat) for a mutant library carrying all possible combinations of six resistance-conferring DHFR mutations and quantified epistatic interactions between them. We found that the high-order epistasis in catalytic power of DHFR (kcat and Km) creates a rugged fitness landscape under trimethoprim selection. Taken together, our data provide a concrete illustration of how epistatic coupling at the level of biochemical parameters can give rise to complex fitness landscapes, and suggest new strategies for developing mutant specific inhibitors.

Citing Articles

Exploring Antibiotic Resistance in Diverse Homologs of the Dihydrofolate Reductase Protein Family through Broad Mutational Scanning.

Romanowicz K, Resnick C, Hinton S, Plesa C bioRxiv. 2025; .

PMID: 39896582 PMC: 11785229. DOI: 10.1101/2025.01.23.634126.


Quantifying protein unfolding kinetics with a high-throughput microfluidic platform.

Atsavapranee B, Sunden F, Herschlag D, Fordyce P bioRxiv. 2025; .

PMID: 39868203 PMC: 11761748. DOI: 10.1101/2025.01.15.633299.


Understanding epistatic networks in the B1 β-lactamases through coevolutionary statistical modeling and deep mutational scanning.

Chen J, Bisardi M, Lee D, Cotogno S, Zamponi F, Weigt M Nat Commun. 2024; 15(1):8441.

PMID: 39349467 PMC: 11442494. DOI: 10.1038/s41467-024-52614-w.


The simplicity of protein sequence-function relationships.

Park Y, Metzger B, Thornton J Nat Commun. 2024; 15(1):7953.

PMID: 39261454 PMC: 11390738. DOI: 10.1038/s41467-024-51895-5.


High throughput mutational scanning of a protein via alchemistry on a high-performance computing resource.

Guclu T, Tayhan B, Cetin E, Atilgan A, Atilgan C bioRxiv. 2024; .

PMID: 39229108 PMC: 11370492. DOI: 10.1101/2024.08.20.608765.


References
1.
Humphrey W, Dalke A, Schulten K . VMD: visual molecular dynamics. J Mol Graph. 1996; 14(1):33-8, 27-8. DOI: 10.1016/0263-7855(96)00018-5. View

2.
Boehr D, McElheny D, Dyson H, Wright P . The dynamic energy landscape of dihydrofolate reductase catalysis. Science. 2006; 313(5793):1638-42. DOI: 10.1126/science.1130258. View

3.
Kwon Y, Lu W, Melamud E, Khanam N, Bognar A, Rabinowitz J . A domino effect in antifolate drug action in Escherichia coli. Nat Chem Biol. 2008; 4(10):602-8. PMC: 2699209. DOI: 10.1038/nchembio.108. View

4.
Pokrovskaya V, Belakhov V, Hainrichson M, Yaron S, Baasov T . Design, synthesis, and evaluation of novel fluoroquinolone-aminoglycoside hybrid antibiotics. J Med Chem. 2009; 52(8):2243-54. DOI: 10.1021/jm900028n. View

5.
Yuthavong Y, Tarnchompoo B, Vilaivan T, Chitnumsub P, Kamchonwongpaisan S, Charman S . Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proc Natl Acad Sci U S A. 2012; 109(42):16823-8. PMC: 3479511. DOI: 10.1073/pnas.1204556109. View